G1 Therapeutics, Inc.·4

Jun 29, 5:56 PM ET

Lee Jacks 4

4 · G1 Therapeutics, Inc. · Filed Jun 29, 2022

Insider Transaction Report

Form 4
Period: 2022-06-27
Lee Jacks
Director
Transactions
  • Award

    Stock Options (Right to buy)

    2022-06-27+60,00060,000 total
    Exercise: $5.35Exp: 2032-06-27Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]The shares underlying this option vest in 36 equal monthly installments beginning on June 30, 2022, subject to the Reporting Person's continued service through each applicable vesting date.

Documents

2 files
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24